Venetoclax with Decitabine as Frontline Treatment for Younger Adults with Newly Diagnosed ELN Adverse-Risk AML No … ← Single cell genomics in acquired bone marrow failure syndromes Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents →